Funding Clinical Trials
Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.
106
CIRM-FUNDED CLINICAL TRIALS
Disease Areas | Investigator | Organization | Phase | Trial Status | Target Enrollment | Detail |
---|---|---|---|---|---|---|
Retinitis Pigmentosa | Dr. Henry John Klassen | University of California, Irvine | Phase 1/2 | Completed | 28 | |
Retinitis Pigmentosa | Henry John Klassen | jCyte, Inc | Phase 2 | Completed | 84 | |
Retinitis Pigmentosa | Henry John Klassen | jCyte, Inc | Phase 2 | Completed | 84 | |
Bone or Cartilage Disease Hearing Loss Intellectual Disability Metabolic Disorders Vision Loss |
Dr Robert Hayes | Immusoft Corporation | Phase 1 | Launching | N/A | |
Corneal Damage | R. Kim Brazzell | Combangio, Inc. | Phase 2 | Launching | N/A | |
Age-related macular degeneration | Dr Jane S Lebkowski | Regenerative Patch Technologies LLC | Phase 2 | Launching | N/A | |
Corneal Damage | Dr. Sophie X Deng | University of California, Los Angeles | Phase 1 | Recruiting | 20 | |
Retinitis Pigmentosa | Clive Svendsen | Cedars-Sinai Medical Center | Phase 1 | Recruiting | 16 | |
Age-related macular degeneration | Dr. Mark S Humayun | University of Southern California | Phase 1 | Unknown status | 16 |